Dialysis Patients Looking to Quit Smoking May Be Eligible for Free Counseling Sessions

2019-01-08T16:38:37+00:00November 30th, 2018|Categories: Costs for Treatment, Early Intervention, eNews, What Causes Kidney Disease|Tags: |

Smoking cigarettes can damage your kidneys. Quitting smoking may help your blood pressure, which can lower your risk for having heart attack or stroke. Individuals with high blood pressure have a higher risk of developing chronic kidney disease (1 in 5 adults with high blood pressure may have chronic kidney disease). Medicare Part B covers up to eight counseling sessions centered around quitting smoking during a 12-month period. Make sure your healthcare professional is recognized by Medicare and accepts Medicare’s payment. Visit Medicare’s website for more information.

Medication Use and the Role of the Pharmacist Recording and Slides

2019-01-04T19:17:04+00:00November 20th, 2018|Categories: eNews, Medication, News & Events, Treatment, Webinar|

If you were unable to attend our last education seminar, the recording is now available! Please see the video and links below for details. We want to keep getting better. Please help us by sharing your comments and suggestions here: Webinar Review View the Recording: Download the slides. Additional Videos Mentioned During Presentation: Patients Stories of Pharmacists' Care Expert Shares Key Steps in Staying Healthy with Kidney Disease Pharmacist Discusses Medications for Kidney Disease

CDC Advises Patients and Their Families to Be Antibiotics Aware

2018-11-15T00:12:33+00:00November 14th, 2018|Categories: eNews, Medication, News & Events, Treatment, What Causes Kidney Disease, What Is Kidney Disease|

People with chronic medical conditions, such as kidney disease, are at a higher risk of getting an infection, which can lead to sepsis. Antibiotics are life-saving drugs and critical tools for treating infections. The Centers for Disease Control and Prevention (CDC) is advising patients and their families to use antibiotics only when necessary to further reduce antibiotic resistance, the spread of superbugs, and protect patients from side effects from antibiotics. During U.S. Antibiotic Awareness Week and throughout the year, CDC promotes Be Antibiotics Aware, an educational effort to raise awareness about the importance of safe antibiotic use. The Be Antibiotics Aware initiative educates the public about [...]

Bladder Health and Chronic Kidney Disease

2018-11-28T18:46:36+00:00November 10th, 2018|Categories: Early Intervention, eNews, Lifestyle, News & Events, Staying Healthy, Treatment|

November is Bladder Health Month. The bladder is part of the urinary system, which also includes the kidneys. Taking care of the bladder is important for individuals with kidney disease as infections in the bladder can spread to the kidneys, which can cause permanent damage to the kidneys. Additionally, diabetes, which is one of the leading causes of chronic kidney disease, can contribute towards bladder problems. The National Institute of Health has some resources on how the bladder changes as we age and ways to keep your bladder healthy. Check out the resources below: Bladder Health for Older Adults – Discusses [...]

Bad News for Individuals with Kidney Disease That Use Marijuana

2018-11-02T15:50:21+00:00October 27th, 2018|Categories: eNews, News & Events, Physical Health, Quality of Life, Stress Management, Treatment|

Individuals with chronic kidney disease (CKD) that use marijuana may lose function of their kidneys more rapidly than non-users, as found in one study. Researchers compared the mean annual rate of decline in estimated glomerular filtration rate (eGFR) among the two groups of participants. The eGFR was 3.22 mL/min/1.73 m2 among marijuana users and 1.42 mL/min/1.73 m2 among non-users. Glomerular filtration rate (GFR) measures kidney function effectiveness by documenting how well the kidneys are filtering the blood. Scientists did not observe a decline in kidney function among individuals that use marijuana and do not have CKD. Read the full article.

RSVP for Next Month’s Webinar – Medication Use and the Role of the Pharmacist

2018-10-23T16:17:32+00:00October 23rd, 2018|Categories: eNews, Medication, News & Events, Treatment, Webinar|

Presented by: Wendy St. Peter, PharmD, FCCP, FASN, FNKF, Professor at the College of Pharmacy, University of Minnesota People with chronic kidney disease (CKD) often times… have other medical conditions require many medicines have several doctors that prescribe medicines go to more than one pharmacy to get medicines It can be hard for patients, doctors and other healthcare professionals to keep track of all the medicines their patients with CKD take. The issues above can lead to medication therapy problems (MTPs). MTPs can…. reduce the good effects of medicines lead to safety issues (e.g., bad reaction to a medicine) result in non-adherence [...]

Positive Psychology Exercises May Help Dialysis Patients Combat Depression

2018-11-29T18:31:33+00:00October 13th, 2018|Categories: eNews, Mental Health, Treatment|

Dialysis patients that participated in technology-based positive psychology exercises reported “significantly” lower symptoms of depression and saw improvements in “quality of life, emotional well-being, physical vigor and social interactions,” as published by one study. The exercises focused on building on the patient’s “personal strengths, cultivating gratitude and using positive reappraisal to reinterpret events.” The findings may provide alternatives for dialysis patients who are looking for ways to manage their depression. Depression is the most common psychiatric illness among individuals with kidney failure, with occurrence ranging from 22.8 to 39.3 percent as reported by a group of researchers. Patients in the study [...]

Taking Statins Before and After Kidney Failure May Lead to Better Outcomes for Dialysis Patients

2018-10-17T16:43:20+00:00October 8th, 2018|Categories: eNews, Medication, News & Events, Treatment|

Individuals with chronic kidney disease (CKD) that took statins at least six months before and after kidney failure had a 28 percent lower risk of death than patients who stopped taking statins after kidney failure, as found in one study. In addition, these individuals had an 18 percent lower risk of cardiovascular-related death when compared to the statin discontinuers. The better cardiovascular outcomes were not observed in studies where individuals with CKD started taking statins after kidney failure, pointing to the importance of early CKD detection and taking statins before and after kidney failure. Statins are drugs taken to lower the [...]

Over $2 Million to be Awarded to Innovative Dialysis Solutions

2018-10-17T16:45:21+00:00October 3rd, 2018|Categories: eNews, News & Events, Treatment|

The US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) are awarding monetary prizes to people that come up with innovative solutions to prevent, diagnose, and treat kidney failure. Anyone is welcome to enter the competition, which is called Kidney Innovation Accelerator (KidneyX), and it is broken up into two phases. The hope is that the contest will generate and expedite new technologies, concepts, or expertise that have not been introduced in the realm of chronic kidney disease. Contest Deadlines and Prize Details Submissions will be accepted from October 2018 until February 2019 for phase [...]

Would You Accept a Kidney from Someone Who Died of a Drug Overdose?

2018-09-24T17:29:36+00:00September 24th, 2018|Categories: eNews, Kidney Transplant, News & Events, Treatment|

The opioid crisis in the US has increased the availability of organs for people looking for a transplant due to drug overdose deaths. As a result, someone in need of a kidney transplant might face a dilemma on whether to accept a kidney in this type of circumstance. One of the potential concerns relates to the organ donor being labeled as having an “increased risk” for contracting hepatitis B, hepatitis C, or HIV, which may not be able to be detected if contracted a week before his/her death. However, the risk is relatively small (less than a 1-in-1,000 chance), and a [...]